Showing results (1-10 of 2,037) with videos related to
Sort By:
Pageof 204
Statistics in Biosciences|July 30, 2010
Evaluating the Impact of Prior Assumptions in Bayesian BiostatisticsSatoshi Morita, Peter F Thall, Peter MüllerBiometrics|September 4, 2007
Determining the effective sample size of a parametric priorSatoshi Morita, Peter F Thall, Peter MüllerBayesian Analysis|November 1, 2013
Prior Effective Sample Size in Conditionally Independent Hierarchical ModelsSatoshi Morita, Peter F Thall, Peter MüllerPharmaceutical Statistics|January 24, 2017
A simulation study of methods for selecting subgroup-specific doses in phase 1 trialsSatoshi Morita, Peter F Thall, Kentaro TakedaJournal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 18, 2011
Placental growth factor and soluble c-kit receptor dynamics characterize the cytokine signature of imatinib in prostate cancer and bone metastasesPaul Mathew, Sijin Wen, Satoshi Morita, et al.Applied Stochastic Models in Business and Industry|December 5, 2017
Clinical Trial Design as a Decision ProblemPeter Müller, Yanxun Xu, Peter F ThallJournal of the Royal Statistical Society. Series C, Applied Statistics|April 15, 2010
A Bayesian hierarchical mixture model for platelet derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancerSatoshi Morita, Peter F Thall, B Nebiyou Bekele, et al.Biometrics|March 4, 2017
Bayesian population finding with biomarkers in a randomized clinical trialSatoshi Morita, Peter MüllerJournal of the American Statistical Association|September 15, 2015
Bayesian Dose-Finding in Two Treatment Cycles Based on the Joint Utility of Efficacy and ToxicityJuhee Lee, Peter F Thall, Yuan Ji, et al.Biostatistics (Oxford, England)|November 11, 2015
A decision-theoretic phase I-II design for ordinal outcomes in two cyclesJuhee Lee, Peter F Thall, Yuan Ji, et al.Pageof 204